XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Marketable Securities
3 Months Ended
Mar. 31, 2022
Marketable Securities [Abstract]  
Marketable Securities . Marketable Securities

 

Available-for-sale marketable securities were as follows (in thousands):

 

 

March 31, 2022

 

 

Amortized
Cost

 

Unrealized
Gains

 

Unrealized
Losses

 

Fair Value

 

Commercial paper

$

50,904

 

$

 

$

 

$

50,904

 

Corporate debt

 

14,814

 

 

1

 

 

(18

)

 

14,797

 

U.S. government agency

 

15,081

 

 

 

 

(20

)

 

15,061

 

Asset-backed securities

 

3,013

 

 

 

 

(6

)

 

3,007

 

Total

$

83,812

 

$

1

 

$

(44

)

$

83,769

 

 

 

December 31, 2021 (1)

 

 

Amortized
Cost

 

Unrealized
Gains

 

Unrealized
Losses

 

Fair Value

 

Commercial paper

$

43,969

 

$

 

$

 

$

43,969

 

Corporate debt

 

17,084

 

 

 

 

(12

)

 

17,072

 

U.S. government agency

 

5,056

 

 

 

 

(3

)

 

5,053

 

Asset-backed securities

 

7,695

 

 

 

 

(5

)

 

7,690

 

Total

$

73,804

 

$

 

$

(20

)

$

73,784

 

 

(1) These items have been reclassified to conform to current period presentation.

All of the Company’s available-for-sale debt marketable securities held as of March 31, 2022 had contractual maturities of less than one year. The Company had 9 securities in an unrealized loss position with an aggregate related fair value of $24.8 million as of March 31, 2022. All securities in an unrealized loss position as of March 31, 2022 had been in a loss position for less than 12 months. Unrealized losses on available-for-sale marketable securities as of March 31, 2022 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, no allowance for credit losses related to the Company’s available-for-sale marketable securities was recorded for the three months ended March 31, 2022. The Company does not intend to sell these securities or expect to be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. The Company recorded interest income of $0.2 million, offset by amortization of premium of $0.1 million, for the three months ended March 31, 2022, which is included in other income, net on the condensed consolidated statements of operations and comprehensive loss.